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Introduction
Chemoprevention and functional foods are new areas of great interest in the prevention of diseases. Further, it has been reported that dietary and environmental factors account about 30% of cancers, suggesting that diet plays an important role in the prevention of cancer (Doll & Peto, 1981) . In the past two decades a large number of dietary compounds have been tested to determine their chemopreventive / anti proliferative activity in vivo/in vitro model systems. Flavonoids are naturally occurring polyphenolic compounds that have very low molecular weight and form a large group of secondary plant metabolites. These compounds have various interesting biological activities such as antioxidative, antimicrobial, anticarcinogenic and cardioprotective (Khan et al., 2008; Moon et al., 2006) . Fisetin a major flavonoid has been reported to possess pharmacological properties like anticancer (Huntington et al., 2004) , angiogenesis-inhibition , antiinflammatory (Kemik et al., 2011) , pro-apoptotic (Liu et al., 2012) and anti-invasive effects (Behrens et al., 2001) . Thus fisetin could confer a valuable advantage in treatment of various types of cancers. Like many other flavonoids, fisetin (3, 3, 4, 7-tetrahydroxy flavone), is widely distributed among fruits and vegetables and is found in plants at a concentration of 160 µg/g (Arai et al., 2000) .
Lung cancer is the second most common cancer and is the major cause of cancer related death in both men and women. Instead of great advancements in chemotherapy survival rates for lung cancer patients is still disappointing. Majority of the lung cancer patients are in stages III and IV when diagnosed making curative surgery difficult. Based on cell morphology pulmonary cancer is primarily categorized into Non Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC). NSCLC is further classified into adenocarcinoma, squamous cell lung carcinoma, and large cell lung carcinoma and comprises nearly 75 to 80% of all lung cancers.The mean 5-year survival rate for those with NSCLC is approximately 15% (Carbone & Felip, 2011) . Recent evidences strongly suggest abnormalities in JAK/STAT signaling pathway is involved in the oncogenesis of several cancers especially lung cancers (Song et al., 2011) . STAT3 is persistently activated in about 50% of NSCLC primary tumors and lung cancer-derived cell lines (Mukohara et al.,2003; Seki et al.,2004; Haura et al., 2005) . Constitutive activation of the P13K/Akt pathway has also been reported in 90% of NSCLC cell lines, thus promoting cell survival and resistance to chemotherapy or γ-radiation (West et al., 2003) .
Exploiting and exploring actions of natural products on suitable model systems has led to development of several life saving drugs available in the market today to treat dreadful diseases. Hence, this study is an attempt to understand the anticancer properties of dietary flavonoid/small molecule inhibitor fisetin on suitable human NSCLC in vitro model systems.
Materials and Methods

Chemicals
Fisetin (3,3′,4′,7-tetrahydroxyflavone) was procured from (sigma , St. Louis , MO, USA). A stock solution of 2.86mg/ ml of fisetin was prepared in DMSO and stored at -20 0 C.
2.2
In-vitro model systems 2.2.1 Isolation and culture of lymphocytes Fresh blood was collected and lymphocytes were separated by following the previously described protocol (Boyum, 1968) . Based on the density gradient centrifugation the lymphocyte separation carried out using separation media (Hisep plates and cultured overnight and treated with fisetin in the dose range of 10 µM to 400 µM concentration and were allowed to proliferate 24/48 h (temperature 37 0 C, 5% CO2 and 95% humidity). After proliferation, MTT performed following the previously described protocol (Mosmann, 1983) . Plates was read at 570nm using a microplate reader and the concentration of fisetin that inhibited cell growth by 50% (IC50) was calculated.
XTT assay
XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) assay was performed using a commercially available kit (HiMedia, Cat. No. CCK015) following the manufacturer's recommendations. Cells after treatment were allowed to proliferate (temperature 37 0 C, 5% CO2 and 95% humidity). Activated XTT solution was added to the wells and cells were incubated for 2 to 4 hours and the absorbance was read at 450 nm using ELISA reader.
Bromodeoxyuridine (BrdU) assay
Cell proliferation was measured by performing BrdU (5-bromo-2'-deoxyuridine) incorporation assay using commercially available kit (Calbiochem/Merck, Cat. No. QIA58, Whitehouse Station, NJ, USA) following the manufacturer's guidelines. The absorbance was recorded at 450 nm and measured intensity is proportional to the amount of incorporated BrdU in the cells.
Crystal violet assay
Crystal violet assay was performed to determine the effect of fisetin on cell viability following the protocol previously described (Lena et al.,2009 ). The treated and untreated control cells were stained with crystal violet (0.05% w/v) for 30 min after that wells were thoroughly washed with distilled water and destained with sorenson's buffer. The absorbance of the extracted stain was measured at 540 nm.
2.4 Assays to determine change in cell morphology and apoptotic cell death
Crystal violet staining
Light microscopy analysis of treated and untreated control cells was carried out by fixing the cells in 10% formalin saline and subsequent staining with 0.05 w/v crystal violet for 30 minutes. Cells were observed under phase contrast microscope and images were captured (4×10X magnification).
Hematoxylin and Eosin staining
Cells after treatment were fixed in 10% formalin and the morphology change in both were analysed by staining the cells with hematoxylin and eosin following the protocol previously described (Fischer et al., 2008) . Cells were observed under light microscope and images were captured (4×10 X magnification).
Soft agar assay for colony formation
A cell suspension (5×10 3 cells/well) in 1ml of 0.3% agar with complete media was over laid on 35mm dish containing 0.5% base agar as described previously (Hamburger et al., 1978) . The media was changed two times a week and cells were maintained under standard growth conditions (temperature 37 0 C, 5% CO2 and 95% humidity) in a CO2 incubator (Forma Scientific, USA). After 15 days, the colonies formed in the untreated control and the treated groups were fixed with 3.7% paraformaldehyde and stained with crystal violet (0.05%) for 1 hour. The colonies were counted under light microscope and images were captured (magnification 10 X).
LDH cytotoxicity assay
The release of lactate dehydrogenase from treated and untreated control cells was performed by using LDHcytotoxicity colorimetric Assay kit 11(catalog no.K313-500) as per the manufacturer's recommendations. After the treatment of cells, the clear medium (10 μl/ well) from treated, control and high control groups was transferred into a clear 96-well plate. LDH reaction mixture (100 μl) was added to each well, and after that plates were incubated for 30 minutes at room temp. The reaction was stopped by adding 10 μl stop solution to each well. The red color intensity representing the LDH activity was measured at the absorbance of 450nm using a microplate reader.
Statistical analysis
Experiments have been carried out in triplicate on at least three different time intervals and the mean of replicate values were taken. All the experimental values were expressed as mean ± SD. Statistical analysis of the data was determined by Student's t-test and comparisons were made between the untreated control and the treated groups.
Results
Determination of IC50 of fisetin on A549 cell line
The Preliminary pilot studies were carried out with various concentrations of fisetin ranging from 10 to 400 µM concentrations. Treatment of A549 cells with 50 µM to 250 µM concentration for 48 h showed a statistically significant ((P<0.001) decrease in proliferation of cells however the concentration above 250 to 400 and below 50 µM showed no appreciable decrease in proliferation of cells when compared to 250 µM concentration (data not shown). Based on MTT assay the concentration of fisetin that inhibited cell growth by 50% (IC50) was determined as 190 µM concentration (Figure 1a ).
Determination of IC50 of fisetin on NCI-H460 cell line
Preliminary pilot studies were carried out with various concentrations of fisetin ranging from 10 to 300 μM concentrations. Treatment of NCI-H460 with 10 to 50 μM concentration for 24 h showed no influence on the proliferation of cells as compared to control (data not shown). Whereas concentrations between 75 to 275μM showed statistically significant (P<0.001) decrease in the proliferation of NCI-H460 cells. Based on MTT assay the concentration of fisetin that inhibited cell growth by 50% (IC50) was determined as 210 µM concentration (Figure 1b ).
Effect of fisetin on growth and proliferation of NCI-H460 and A549 cell line
Based on preliminary pilot studies, the 1C50 doses were further confirmed by performing XTT, BrdU, crystal violet assays (Figure 2, 3, 4) .These assays were performed to confirm results obtained from MTT assay and these assays were in agreement. Based on these cell viability and proliferation assays it was observed that treatment with the specified concentrations of fisetin resulted in statistically significant decrease in cell viability, growth, survival and proliferation of A549 and NCI-H460 cells .The IC50 doses were confirmed and used for carrying out further assays. 
Effect of fisetin on cloning efficiency and surviving fraction
Results revealed that A549 control cells showed a cloning efficiency of 0.82 as compared to cloning efficiency of 0.28 observed in treated cells and NCI-H460 control cells showed a cloning efficiency of 1.18 as compared to cloning efficiency of 0.34 observed in treated cells. Thus, it illustrates the significant decrease in the number of colonies and decrease in percentage of survival in fistein treated groups compared to that of untreated control (Table 1) . As shown in figure fisetin treatment almost completely blocked the migration of A549 and NCI-H460 cells, and antimetastatic effect was more evident in NCI-H460 treated cells (Fig. 5 C) .
Effect of fisetin on release of LDH
Results indicate that the cells treated with fisetin showed marked increase in LDH release in both A549 and NCI-H460 cells which was found to be statistically significant ( p<0.001) as compared to untreated control ( Figure 6 ).
Discussion
Currently over 50% of anticancer drugs available in the market for therapy werederived directly or indirectly from natural source (Younes et al., 2007) . Dietary factors play an important role in prevention of cancer, hence large number of dietary compounds were tested to determine their chemopreventive / antiproliferative ability in invivo / invitro model systems. A549 cells were derived from human alveolar carcinoma cell (Giard et al., 1973) and matched closely with type II alveolar cell phenotype. They share many characteristic features with human primary alveolar epithelial cell (Lieber et al., 1976) . Hence they are widely used as models of lung cancer (Wang et al., 2009; Shin et al., 2009 )and as human primary alveolar epithelial cells in vitro (Tian et al., 2009; Mazzarella et al., 2007) . NCI-H460 cells are epithelioid cells isolated from pleural fluid of a patient with large cell carcinoma of lung. Inhibition of cell proliferation is a characteristic feature of majority of anticancer agents. The flavonoid fisetin was reported to inhibit cell proliferation against several in vivo/in vitro models of carcinogenesis. The current study also showed significant inhibition of cell growth and proliferation was observed after treatment of pulmonary carcinoma cells with fisetin. In human, the Quadraplex (G4) forming sequences in telomeric DNA and C-myc promoter regions of DNA are associated with tumorigenesis. Ligands that can help to facilitate or stabilize formation of G4quadraplex structures and increase stabilization of G4quadraplex can prevent tumor cell proliferation and regarded as promising candidates as anti-cancer agents (Sen gupta et al., 2013) . In the recent years, particular efforts are under way to discover, design and synthesise new ligands that could help to regulate the stability of G-quadraplex structures. Fisetin is reported to act as a ligand for G4 DNA (Sengupta et al., 2013) , and hence could have a tight control on the cell proliferation in A549 and NCI-H460 cells. This could be the reason for the observed inhibitory effects of fisetin on cell growth, viability and proliferation of pulmonary carcinoma cell lines. Neoplastic transformation takes place via a series of genetic and epigenetic changes that yield cell population with potential of proliferating independently of both external and internal signals. It is one of the hall marks of malignant transformation and most accurate in vitro indication of tumorigenicity (Shin et al., 1975) . The decreased number of colonies and inhibition of anchorage independent growth of pulmonary carcinoma cells by fisetin strongly supported its potent antiproliferative effects.
Hematoxylin and eosin staining is a valuable indicator of morphological and tissue architectural changes occurring during pathological conditions. This is an indispensible test to confirm malignant transformation of normal cells or to test efficacy of compounds to prevent pathological changes in cells/tissues. Results of hematoxylin and eosin staining were in line and support observations of cell growth assays, clonogenic assay. This confirmed growth inhibitory effects of fisetin on A549 and NCI-H40 cells. LDH is a cytosolic enzyme that leaks into culture supernatant or serum during membrane damage and injury. Increased leakage of LDH into culture supernatant of cells treated with fisetin implies alteration in membrane permeability and integrity thereby results in increased leakage of enzyme out of cells.
Conclusion
The results of the current study indicate growth inhibitory, antiproliferative and cytotoxic effects of fisetin on human pulmonary carcinoma cells A-549 and NCI-H460. Although the mechanism of action remains unclear at this stage of the study, it is presumed to be due to proapoptotic effects of fisetin and its subsequent implications on multiple cell signaling pathways that mediate cell proliferation and death.
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